scholarly journals Epidemiological Outbreaks of Pneumocystis jirovecii Pneumonia Are Not Limited to Kidney Transplant Recipients: Genotyping Confirms Common Source of Transmission in a Liver Transplantation Unit

2016 ◽  
Vol 54 (5) ◽  
pp. 1314-1320 ◽  
Author(s):  
Guillaume Desoubeaux ◽  
Manon Dominique ◽  
Florent Morio ◽  
Rose-Anne Thepault ◽  
Claire Franck-Martel ◽  
...  

Over a 5-month period, four liver transplant patients at a single hospital were diagnosed withPneumocystis jiroveciipneumonia (PCP). This unusually high incidence was investigated using molecular genotyping. Bronchoalveolar lavage fluids (BALF) obtained from the four liver recipients diagnosed with PCP were processed for multilocus sequence typing (MLST) at three loci (SOD, mt26s, andCYB). Twenty-four other BALF samples, which were positive forP. jiroveciiand collected from 24 epidemiologically unrelated patients with clinical signs of PCP, were studied in parallel by use of the same method.Pneumocystis jiroveciiisolates from the four liver recipients all had the same genotype, which was different from those of the isolates from all the epidemiologically unrelated individuals studied. These findings supported the hypothesis of a common source of contamination or even cross-transmission of a singleP. jiroveciiclone between the four liver recipients. Hospitalization mapping showed several possible encounters between these four patients, including outpatient consultations on one particular date when they all possibly met. This study demonstrates the value of molecular genotyping ofP. jiroveciiisolated from clinical samples for epidemiological investigation of PCP outbreaks. It is also the first description of a common source of exposure to a singleP. jiroveciiclone between liver transplant recipients and highlights the importance of prophylaxis in such a population.

Author(s):  
Norihiko Goto ◽  
Kenta Futamura ◽  
Manabu Okada ◽  
Takayuki Yamamoto ◽  
Makoto Tsujita ◽  
...  

The outbreak of Pneumocystis jirovecii pneumonia (PJP) among kidney transplant recipients is emerging worldwide. It is important to control nosocomial PJP infection. A delay in diagnosis and treatment increases the number of reservoir patients and the number of cases of respiratory failure and death. Owing to the large number of kidney transplant recipients compared to other types of organ transplantation, there are greater opportunities for them to share the same time and space. Although the use of trimethoprim-sulfamethoxazole (TMP-SMX) as first choice in PJP prophylaxis is valuable for PJP that develops from infections by trophic forms, it cannot prevent or clear colonization, in which cysts are dominant. Colonization of P. jirovecii is cleared by macrophages. While recent immunosuppressive therapies have decreased the rate of rejection, over-suppressed macrophages caused by the higher levels of immunosuppression may decrease the eradication rate of colonization. Once a PJP cluster enters these populations, which are gathered in one place and uniformly undergoing immunosuppressive therapy for kidney transplantation, an outbreak can occur easily. Quick actions for PJP patients, other recipients, and medical staff of transplant centers are required. In future, lifelong prophylaxis may be required even in kidney transplant recipients.


2011 ◽  
Vol 92 (12) ◽  
pp. 1327-1334 ◽  
Author(s):  
Lisa M. Phipps ◽  
Sharon C.-A. Chen ◽  
Kathy Kable ◽  
Catriona L. Halliday ◽  
Carolina Firacative ◽  
...  

Author(s):  
Philip B. Andreasen ◽  
Omid Rezahosseini ◽  
Dina L. Møller ◽  
Neval E. Wareham ◽  
Magda T. Thomsen ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document